The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, while on extracorporeal circulation, blood leakage was observed at the lower side of connection part of the shunt sensor.There was a blood loss of 10ml or less.Product was changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on january 15, 2019.Upon further investigation of the reported event, the following information is new and/or changed: device availability - added date returned to manufacturer; date received by manufacturer; indication that this is a follow-up report; follow-up due to additional information and device evaluation; device evaluated by manufacturer; identification of evaluation codes 10, 213, 67.Method code: 10 - testing of actual/suspected device; results code: 213 - no device problem found; conclusions code: 67 - no problem detected.The returned sample was visually inspected and was noted to contain dried blood within the threads of the large bore cap.It was then leak tested (as received) by connecting with the calibrated manometer, submerged into a water bath, and pressurized up to 1030 mmhg.A leak was noted at approximately 400 mmhg.The large blue cap was then loosened and retightened by hand.The sample was then leak tested for the second time, and no leaks were noted.The lot number was not provided; therefore, testing of a retention sample could not be completed.The root cause for this event was determined to be the large blue vent cap for shunt sensor was not fully tightened either during setup of the circuit, or after the gas calibration.When the large blue vent cap was loosened, it had not been re-tightened fully prior to use in the line, causing a leak from the cap.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|